{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:43:44Z","timestamp":1791546224579,"version":"4.3.4"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Project of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200065"],"award-info":[{"award-number":["82200065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Project of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82241007"],"award-info":[{"award-number":["82241007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Project of National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82170058"],"award-info":[{"award-number":["82170058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Pujiang Program","award":["22PJ1410100"],"award-info":[{"award-number":["22PJ1410100"]}]},{"name":"Young Talent Program of Shanghai Municipal Health Commission","award":["2022YQ070"],"award-info":[{"award-number":["2022YQ070"]}]},{"name":"Joint Fund for Scince and Technology R&D Plan of Henan Commission","award":["232103810056"],"award-info":[{"award-number":["232103810056"]}]},{"name":"Special Project for Key R&D and Promotion of Henan Province","award":["232102311233"],"award-info":[{"award-number":["232102311233"]}]},{"name":"Special Project for Key R&D Plan and Promotion of Henan Province","award":["242102311034"],"award-info":[{"award-number":["242102311034"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10557-024-07655-0","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:28:19Z","timestamp":1733704099000},"page":"1549-1565","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cytochrome P450-derived Epoxyeicosatrienoic Acid, the Regulation of Cardiovascular-related Diseases, and the Implication for Pulmonary Hypertension"],"prefix":"10.1007","volume":"39","author":[{"given":"Run","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Fang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-He","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Jian","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Da","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"issue":"1","key":"7655_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"N Galie","year":"2016","unstructured":"Galie N, Humbert M, Vachiery JL, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67\u2013119. https:\/\/doi.org\/10.1093\/eurheartj\/ehv317.","journal-title":"Eur Heart J"},{"issue":"18","key":"7655_CR2","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.jacc.2015.03.540","volume":"65","author":"VV McLaughlin","year":"2015","unstructured":"McLaughlin VV, Shah SJ, Souza R, Humbert M. Management of pulmonary arterial hypertension. J Am Coll Cardiol. 2015;65(18):1976\u201397. https:\/\/doi.org\/10.1016\/j.jacc.2015.03.540.","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"7655_CR3","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1161\/CIRCULATIONAHA.114.006974","volume":"130","author":"M Humbert","year":"2014","unstructured":"Humbert M, Lau EM, Montani D, et al. Advances in therapeutic interventions for patients with pulmonary arterial hypertension. Circulation. 2014;130(24):2189\u2013208. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.006974.","journal-title":"Circulation"},{"issue":"19","key":"7655_CR4","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1161\/CIRCULATIONAHA.114.006979","volume":"131","author":"JJ Ryan","year":"2015","unstructured":"Ryan JJ, Archer SL. Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension. Circulation. 2015;131(19):1691\u2013702. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.006979.","journal-title":"Circulation"},{"issue":"3","key":"7655_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1183\/09031936.00151313","volume":"43","author":"JL Cracowski","year":"2014","unstructured":"Cracowski JL, Chabot F, Labarere J, et al. Proinflammatory cytokine levels are linked to death in pulmonary arterial hypertension. Eur Respiratory J. 2014;43(3):915\u20137. https:\/\/doi.org\/10.1183\/09031936.00151313.","journal-title":"Eur Respiratory J: Off J Eur Soc Clin Respiratory Phys"},{"issue":"9","key":"7655_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1161\/CIRCULATIONAHA.109.933762","volume":"122","author":"E Soon","year":"2010","unstructured":"Soon E, Holmes AM, Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation. 2010;122(9):920\u20137. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933762.","journal-title":"Circulation"},{"key":"7655_CR7","doi-asserted-by":"publisher","unstructured":"He Y-Y, Yan Y, Jiang X, et al. Spermine promotes pulmonary vascular remodelling and its synthase is a therapeutic target for pulmonary arterial hypertension. Eur Respiratory J. 2020;56(5). https:\/\/doi.org\/10.1183\/13993003.00522-2020.","DOI":"10.1183\/13993003.00522-2020"},{"key":"7655_CR8","doi-asserted-by":"publisher","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ (Clinical research ed). 2018;360:j5492. https:\/\/doi.org\/10.1136\/bmj.j5492.","journal-title":"BMJ (Clinical research ed)"},{"key":"7655_CR9","doi-asserted-by":"publisher","first-page":"108454","DOI":"10.1016\/j.pharmthera.2023.108454","volume":"248","author":"C McReynolds","year":"2023","unstructured":"McReynolds C, Hammock B, Morisseau C. Regulatory lipid vicinal diols counteract the biological activity of epoxy fatty acids and can act as biomarkers and mechanisms for disease progression. Pharmacol Ther. 2023;248:108454. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108454.","journal-title":"Pharmacol Ther"},{"key":"7655_CR10","doi-asserted-by":"publisher","first-page":"106385","DOI":"10.1016\/j.prostaglandins.2019.106385","volume":"147","author":"J Atone","year":"2020","unstructured":"Atone J, Wagner K, Hashimoto K, Hammock BD. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. Prostaglandins Other Lipid Mediat. 2020;147:106385. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106385.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"7655_CR11","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev.pa.31.040191.002011","volume":"31","author":"JC McGiff","year":"1991","unstructured":"McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol. 1991;31:339\u201369. https:\/\/doi.org\/10.1146\/annurev.pa.31.040191.002011.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7655_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pharmthera.2017.05.005","volume":"179","author":"KL Jamieson","year":"2017","unstructured":"Jamieson KL, Endo T, Darwesh AM, Samokhvalov V, Seubert JM. Cytochrome P450-derived eicosanoids and heart function. Pharmacol Ther. 2017;179:47\u201383. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.05.005.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"7655_CR13","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1194\/jlr.M006007","volume":"51","author":"C Morisseau","year":"2010","unstructured":"Morisseau C, Inceoglu B, Schmelzer K, et al. Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids. J Lipid Res. 2010;51(12):3481\u201390. https:\/\/doi.org\/10.1194\/jlr.M006007.","journal-title":"J Lipid Res"},{"issue":"6","key":"7655_CR14","doi-asserted-by":"publisher","first-page":"H2412","DOI":"10.1152\/ajpheart.00527.2004","volume":"287","author":"X Fang","year":"2004","unstructured":"Fang X, Weintraub NL, McCaw RB, et al. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels. Am J Physiol Heart Circ Physiol. 2004;287(6):H2412\u201320. https:\/\/doi.org\/10.1152\/ajpheart.00527.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3\u20134","key":"7655_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10555-011-9315-y","volume":"30","author":"D Panigrahy","year":"2011","unstructured":"Panigrahy D, Greene ER, Pozzi A, Wang DW, Zeldin DC. EET signaling in cancer. Cancer Metastasis Rev. 2011;30(3\u20134):525\u201340. https:\/\/doi.org\/10.1007\/s10555-011-9315-y.","journal-title":"Cancer Metastasis Rev"},{"issue":"9","key":"7655_CR16","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1097\/FPC.0b013e32810f2e58","volume":"17","author":"I Bi\u00e8che","year":"2007","unstructured":"Bi\u00e8che I, Narjoz C, Asselah T, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics. 2007;17(9):731\u201342. https:\/\/doi.org\/10.1097\/FPC.0b013e32810f2e58.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"7655_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbapap.2010.09.009","volume":"1814","author":"A Konkel","year":"2011","unstructured":"Konkel A, Schunck W-H. Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids. Biochem Biophys Acta. 2011;1814(1):210\u201322. https:\/\/doi.org\/10.1016\/j.bbapap.2010.09.009.","journal-title":"Biochem Biophys Acta"},{"issue":"2","key":"7655_CR18","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1164\/ajrccm\/136.2.488","volume":"136","author":"JC McGiff","year":"1987","unstructured":"McGiff JC, Carroll MA. Cytochrome P-450-related arachidonic acid metabolites. Am Rev Respir Dis. 1987;136(2):488\u201391. https:\/\/doi.org\/10.1164\/ajrccm\/136.2.488.","journal-title":"Am Rev Respir Dis"},{"issue":"11","key":"7655_CR19","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1016\/S0022-2275(20)35111-7","volume":"34","author":"M VanRollins","year":"1993","unstructured":"VanRollins M, Kaduce TL, Knapp HR, Spector AA. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells. J Lipid Res. 1993;34(11):1931\u201342.","journal-title":"J Lipid Res"},{"issue":"6","key":"7655_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/S0022-2275(20)41131-9","volume":"36","author":"X Fang","year":"1995","unstructured":"Fang X, VanRollins M, Kaduce TL, Spector AA. Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells. J Lipid Res. 1995;36(6):1236\u201346.","journal-title":"J Lipid Res"},{"issue":"4\u20135","key":"7655_CR21","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0952-3278(97)90412-9","volume":"57","author":"X Fang","year":"1997","unstructured":"Fang X, Kaduce TL, Weintraub NL, Spector AA. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. Prostaglandins Leukot Essent Fatty Acids. 1997;57(4\u20135):367\u201371.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"24","key":"7655_CR22","doi-asserted-by":"publisher","first-page":"14001","DOI":"10.1074\/jbc.271.24.14001","volume":"271","author":"M VanRollins","year":"1996","unstructured":"VanRollins M, Kaduce TL, Fang X, Knapp HR, Spector AA. Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells. J Biol Chem. 1996;271(24):14001\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"7655_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1096\/fj.10-171488","volume":"25","author":"Y Deng","year":"2011","unstructured":"Deng Y, Edin ML, Theken KN, et al. Endothelial CYP epoxygenase overexpression and soluble epoxide hydrolase disruption attenuate acute vascular inflammatory responses in mice. FASEB J. 2011;25(2):703\u201313. https:\/\/doi.org\/10.1096\/fj.10-171488.","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"issue":"28","key":"7655_CR24","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1073\/pnas.0503279102","volume":"102","author":"KR Schmelzer","year":"2005","unstructured":"Schmelzer KR, Kubala L, Newman JW, et al. Soluble epoxide hydrolase is a therapeutic target for acute inflammation. Proc Natl Acad Sci USA. 2005;102(28):9772\u20137. https:\/\/doi.org\/10.1073\/pnas.0503279102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"7655_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12931-021-01891-w","volume":"22","author":"Y Ding","year":"2021","unstructured":"Ding Y, Tu P, Chen Y, et al. CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro. Respir Res. 2021;22(1):291. https:\/\/doi.org\/10.1186\/s12931-021-01891-w.","journal-title":"Respir Res"},{"issue":"5431","key":"7655_CR26","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","volume":"285","author":"K Node","year":"1999","unstructured":"Node K, Huo Y, Ruan X, et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science. 1999;285(5431):1276\u20139.","journal-title":"Science"},{"issue":"3","key":"7655_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3892\/ijmm.2014.1844","volume":"34","author":"W Liu","year":"2014","unstructured":"Liu W, Wang B, Ding H, Wang DW, Zeng H. A potential therapeutic effect of CYP2C8 overexpression on anti-TNF-\u03b1 activity. Int J Mol Med. 2014;34(3):725\u201332. https:\/\/doi.org\/10.3892\/ijmm.2014.1844.","journal-title":"Int J Mol Med"},{"issue":"9","key":"7655_CR28","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1002\/jcp.24939","volume":"230","author":"M Dai","year":"2015","unstructured":"Dai M, Wu L, He Z, et al. Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction. J Cell Physiol. 2015;230(9):2108\u201319. https:\/\/doi.org\/10.1002\/jcp.24939.","journal-title":"J Cell Physiol"},{"key":"7655_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/bph.16009","author":"HB Abdalla","year":"2022","unstructured":"Abdalla HB, Alvarez C, Wu Y-C, et al. Soluble epoxide hydrolase inhibition enhances production of specialized pro-resolving lipid mediator and promotes macrophage plasticity. Br J Pharmacol. 2022. https:\/\/doi.org\/10.1111\/bph.16009.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"7655_CR30","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1097\/shk.0000000000001408","volume":"53","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tang Y, Yu J, et al. sEH inhibitor Tppu ameliorates cecal ligation and puncture-induced sepsis by regulating macrophage functions. Shock (Augusta, Ga). 2020;53(6):761\u201371. https:\/\/doi.org\/10.1097\/shk.0000000000001408.","journal-title":"Shock (Augusta, Ga)"},{"issue":"3","key":"7655_CR31","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1021\/acscentsci.2c01424","volume":"9","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang M, Huo X-K, et al. Macrophage inactivation by small molecule wedelolactone via targeting sEH for the treatment of LPS-induced acute lung injury. ACS Cent Sci. 2023;9(3):440\u201356. https:\/\/doi.org\/10.1021\/acscentsci.2c01424.","journal-title":"ACS Cent Sci"},{"key":"7655_CR32","doi-asserted-by":"publisher","unstructured":"Ikeda N, Asano K, Kikuchi K, et al. Emergence of immunoregulatory Ym1+Ly6Chi monocytes during recovery phase of tissue injury. Sci Immun. 2018;3(28). https:\/\/doi.org\/10.1126\/sciimmunol.aat0207.","DOI":"10.1126\/sciimmunol.aat0207"},{"key":"7655_CR33","doi-asserted-by":"publisher","unstructured":"Li X, Kempf S, G\u00fcnther S, Hu J, Fleming I. 11,12-EET regulates PPAR-\u03b3 expression to modulate TGF-\u03b2-mediated macrophage polarization. Cells. 2023;12(5). https:\/\/doi.org\/10.3390\/cells12050700.","DOI":"10.3390\/cells12050700"},{"key":"7655_CR34","doi-asserted-by":"publisher","first-page":"1152881","DOI":"10.3389\/fimmu.2023.1152881","volume":"14","author":"M-Q Zhang","year":"2023","unstructured":"Zhang M-Q, Wang C-C, Pang X-B, et al. Role of macrophages in pulmonary arterial hypertension. Front Immunol. 2023;14:1152881. https:\/\/doi.org\/10.3389\/fimmu.2023.1152881.","journal-title":"Front Immunol"},{"key":"7655_CR35","doi-asserted-by":"publisher","first-page":"154380","DOI":"10.1016\/j.phymed.2022.154380","volume":"107","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang M, Zhang W-H, et al. Total flavonoids of Inula japonica alleviated the inflammatory response and oxidative stress in LPS-induced acute lung injury via inhibiting the sEH activity: insights from lipid metabolomics. Phytomed. 2022;107:154380. https:\/\/doi.org\/10.1016\/j.phymed.2022.154380.","journal-title":"Phytomed: Int J Phytother Phytopharmacol"},{"issue":"2","key":"7655_CR36","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1159\/000445663","volume":"39","author":"C Zhou","year":"2016","unstructured":"Zhou C, Huang J, Chen J, et al. CYP2J2-derived EETs attenuated angiotensin II-induced adventitial remodeling via reduced inflammatory response. Cell Physiol Biochem. 2016;39(2):721\u201339. https:\/\/doi.org\/10.1159\/000445663.","journal-title":"Cell Physiol Biochem: Int J Exp Cell Physiol Biochem Pharmacol"},{"issue":"12","key":"7655_CR37","doi-asserted-by":"publisher","first-page":"9910","DOI":"10.1002\/jcp.29806","volume":"235","author":"X-Q Luo","year":"2020","unstructured":"Luo X-Q, Duan J-X, Yang H-H, et al. Epoxyeicosatrienoic acids inhibit the activation of NLRP3 inflammasome in murine macrophages. J Cell Physiol. 2020;235(12):9910\u201321. https:\/\/doi.org\/10.1002\/jcp.29806.","journal-title":"J Cell Physiol"},{"issue":"1","key":"7655_CR38","doi-asserted-by":"publisher","first-page":"10522","DOI":"10.1038\/s41598-017-11274-1","volume":"7","author":"A Berna-Erro","year":"2017","unstructured":"Berna-Erro A, Izquierdo-Serra M, Sep\u00falveda RV, et al. Structural determinants of 5\u2019,6\u2019-epoxyeicosatrienoic acid binding to and activation of TRPV4 channel. Sci Rep. 2017;7(1):10522. https:\/\/doi.org\/10.1038\/s41598-017-11274-1.","journal-title":"Sci Rep"},{"issue":"6","key":"7655_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41419-019-1612-3","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhou L, An D, et al. TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice. Cell Death Dis. 2019;10(6):386. https:\/\/doi.org\/10.1038\/s41419-019-1612-3.","journal-title":"Cell Death Dis"},{"issue":"1","key":"7655_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0006-291X(90)91741-A","volume":"167","author":"KA Pritchard Jr","year":"1990","unstructured":"Pritchard KA Jr, Tota RR, Stemerman MB, Wong PY. 14, 15-Epoxyeicosatrienoic acid promotes endothelial cell dependent adhesion of human monocytic tumor U937 cells. Biochem Biophys Res Commun. 1990;167(1):137\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"7655_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.prostaglandins.2015.01.004","volume":"116\u2013117","author":"L Yang","year":"2015","unstructured":"Yang L, Ni L, Duan Q, et al. CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages. Prostaglandins Other Lipid Mediat. 2015;116\u2013117:64\u201375. https:\/\/doi.org\/10.1016\/j.prostaglandins.2015.01.004.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"7655_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.plefa.2014.10.006","volume":"94","author":"WJ Ma","year":"2015","unstructured":"Ma WJ, Sun YH, Jiang JX, et al. Epoxyeicosatrienoic acids attenuate cigarette smoke extract-induced interleukin-8 production in bronchial epithelial cells. Prostaglandins Leukot Essent Fatty Acids. 2015;94:13\u20139. https:\/\/doi.org\/10.1016\/j.plefa.2014.10.006.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"7655_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2014.01.045","volume":"727","author":"JX Jiang","year":"2014","unstructured":"Jiang JX, Zhang SJ, Liu YN, et al. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells. Eur J Pharmacol. 2014;727:43\u201351. https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.045.","journal-title":"Eur J Pharmacol"},{"key":"7655_CR44","doi-asserted-by":"publisher","first-page":"105291","DOI":"10.1016\/j.neuint.2022.105291","volume":"154","author":"X Chen","year":"2022","unstructured":"Chen X, Li Z, Zhang B, et al. Antinociception role of 14,15-epoxyeicosatrienoic acid in a central post-stroke pain model in rats mediated by anti-inflammation and anti-apoptosis effect. Neurochem Int. 2022;154:105291. https:\/\/doi.org\/10.1016\/j.neuint.2022.105291.","journal-title":"Neurochem Int"},{"issue":"1","key":"7655_CR45","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12974-021-02255-3","volume":"18","author":"T Liu","year":"2021","unstructured":"Liu T, Li T, Chen X, et al. EETs\/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model. J Neuroinflammation. 2021;18(1):211. https:\/\/doi.org\/10.1186\/s12974-021-02255-3.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"7655_CR46","doi-asserted-by":"publisher","first-page":"L970","DOI":"10.1152\/ajplung.00161.2016","volume":"311","author":"Y Li","year":"2016","unstructured":"Li Y, Yu G, Yuan S, et al. 14,15-Epoxyeicosatrienoic acid suppresses cigarette smoke condensate-induced inflammation in lung epithelial cells by inhibiting autophagy. Am J Physiol Lung Cell Mol Physiol. 2016;311(5):L970\u201380. https:\/\/doi.org\/10.1152\/ajplung.00161.2016.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"7655_CR47","doi-asserted-by":"publisher","unstructured":"Liu P, Zhang S, Gao J, et al. Downregulated serum 14, 15-epoxyeicosatrienoic acid is associated with abdominal aortic calcification in patients with primary aldosteronism. Hypertension. 2018;71(4):592\u20138. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10644.","DOI":"10.1161\/hypertensionaha.117.10644"},{"issue":"2","key":"7655_CR48","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1194\/jlr.M031914","volume":"54","author":"S Kundu","year":"2013","unstructured":"Kundu S, Roome T, Bhattacharjee A, et al. Metabolic products of soluble epoxide hydrolase are essential for monocyte chemotaxis to MCP-1 in vitro and in vivo. J Lipid Res. 2013;54(2):436\u201347. https:\/\/doi.org\/10.1194\/jlr.M031914.","journal-title":"J Lipid Res"},{"key":"7655_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1476-511X-12-151","volume":"12","author":"T Yang","year":"2013","unstructured":"Yang T, Peng R, Guo Y, et al. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. Lipids Health Dis. 2013;12:151. https:\/\/doi.org\/10.1186\/1476-511X-12-151.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"7655_CR50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.atherosclerosis.2013.01.034","volume":"227","author":"RN Schuck","year":"2013","unstructured":"Schuck RN, Theken KN, Edin ML, et al. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients. Atherosclerosis. 2013;227(2):442\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.01.034.","journal-title":"Atherosclerosis"},{"issue":"1","key":"7655_CR51","doi-asserted-by":"publisher","first-page":"16555","DOI":"10.1038\/s41598-021-96014-2","volume":"11","author":"CB Bergmann","year":"2021","unstructured":"Bergmann CB, Hammock BD, Wan D, et al. TPPU treatment of burned mice dampens inflammation and generation of bioactive DHET which impairs neutrophil function. Sci Rep. 2021;11(1):16555. https:\/\/doi.org\/10.1038\/s41598-021-96014-2.","journal-title":"Sci Rep"},{"issue":"3","key":"7655_CR52","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00424-013-1303-3","volume":"466","author":"DC Ellinsworth","year":"2014","unstructured":"Ellinsworth DC, Earley S, Murphy TV, Sandow SL. Endothelial control of vasodilation: integration of myoendothelial microdomain signalling and modulation by epoxyeicosatrienoic acids. Pflugers Arch. 2014;466(3):389\u2013405. https:\/\/doi.org\/10.1007\/s00424-013-1303-3.","journal-title":"Pflugers Arch"},{"key":"7655_CR53","doi-asserted-by":"publisher","first-page":"753727","DOI":"10.3389\/fphar.2021.753727","volume":"12","author":"Y-Y He","year":"2021","unstructured":"He Y-Y, Xie X-M, Zhang H-D, et al. Identification of hypoxia induced metabolism associated genes in pulmonary hypertension. Front Pharmacol. 2021;12:753727. https:\/\/doi.org\/10.3389\/fphar.2021.753727.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7655_CR54","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1111\/apha.13521","volume":"230","author":"I Strielkov","year":"2020","unstructured":"Strielkov I, Krause NC, Knoepp F, et al. Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia. Acta Physiol (Oxf). 2020;230(1):e13521. https:\/\/doi.org\/10.1111\/apha.13521.","journal-title":"Acta Physiol (Oxf)"},{"issue":"4 Pt 2","key":"7655_CR55","first-page":"H1171","volume":"259","author":"EF Ellis","year":"1990","unstructured":"Ellis EF, Police RJ, Yancey L, McKinney JS, Amruthesh SC. Dilation of cerebral arterioles by cytochrome P-450 metabolites of arachidonic acid. Am J Physiol. 1990;259(4 Pt 2):H1171\u20137.","journal-title":"Am J Physiol"},{"issue":"2 Pt 2","key":"7655_CR56","first-page":"H519","volume":"263","author":"D Gebremedhin","year":"1992","unstructured":"Gebremedhin D, Ma YH, Falck JR, et al. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 1992;263(2 Pt 2):H519\u201325.","journal-title":"Am J Physiol"},{"issue":"2 Pt 2","key":"7655_CR57","first-page":"H327","volume":"264","author":"M Rosolowsky","year":"1993","unstructured":"Rosolowsky M, Campbell WB. Role of PGI2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 1993;264(2 Pt 2):H327\u201335.","journal-title":"Am J Physiol"},{"issue":"9","key":"7655_CR58","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/01.RES.0000018162.87285.F8","volume":"90","author":"KM Gauthier","year":"2002","unstructured":"Gauthier KM, Deeter C, Krishna UM, et al. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 2002;90(9):1028\u201336.","journal-title":"Circ Res"},{"issue":"4","key":"7655_CR59","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1161\/01.HYP.0000153462.06604.5d","volume":"45","author":"KM Gauthier","year":"2005","unstructured":"Gauthier KM, Edwards EM, Falck JR, Reddy DS, Campbell WB. 14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries. Hypertension. 2005;45(4):666\u201371. https:\/\/doi.org\/10.1161\/01.HYP.0000153462.06604.5d.","journal-title":"Hypertension"},{"issue":"4","key":"7655_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1161\/01.HYP.0000091265.94045.C7","volume":"42","author":"KM Gauthier","year":"2003","unstructured":"Gauthier KM, Jagadeesh SG, Falck JR, Campbell WB. 14,15-epoxyeicosa-5(Z)-enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries. Hypertension. 2003;42(4):555\u201361. https:\/\/doi.org\/10.1161\/01.HYP.0000091265.94045.C7.","journal-title":"Hypertension"},{"issue":"2","key":"7655_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/01.RES.81.2.258","volume":"81","author":"NL Weintraub","year":"1997","unstructured":"Weintraub NL, Fang X, Kaduce TL, et al. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids. Circ Res. 1997;81(2):258\u201367.","journal-title":"Circ Res"},{"issue":"6","key":"7655_CR62","doi-asserted-by":"publisher","first-page":"H1990","DOI":"10.1152\/ajpheart.01267.2010","volume":"300","author":"H Jiang","year":"2011","unstructured":"Jiang H, Quilley J, Doumad AB, et al. Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol. 2011;300(6):H1990\u20136. https:\/\/doi.org\/10.1152\/ajpheart.01267.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"7655_CR63","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/01.HYP.34.6.1242","volume":"34","author":"X Fang","year":"1999","unstructured":"Fang X, Weintraub NL, Stoll LL, Spector AA. Epoxyeicosatrienoic acids increase intracellular calcium concentration in vascular smooth muscle cells. Hypertension. 1999;34(6):1242\u20136.","journal-title":"Hypertension"},{"issue":"8","key":"7655_CR64","doi-asserted-by":"publisher","first-page":"H1146","DOI":"10.1152\/ajpheart.00920.2013","volume":"306","author":"D Sun","year":"2014","unstructured":"Sun D, Cuevas AJ, Gotlinger K, et al. Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure. Am J Physiol Heart Circ Physiol. 2014;306(8):H1146\u201353. https:\/\/doi.org\/10.1152\/ajpheart.00920.2013.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"7655_CR65","doi-asserted-by":"publisher","first-page":"H1448","DOI":"10.1152\/ajpheart.00906.2015","volume":"310","author":"G Froogh","year":"2016","unstructured":"Froogh G, Qin J, Kandhi S, et al. Female-favorable attenuation of coronary myogenic constriction via reciprocal activations of epoxyeicosatrienoic acids and nitric oxide. Am J Physiol Heart Circ Physiol. 2016;310(11):H1448\u201354. https:\/\/doi.org\/10.1152\/ajpheart.00906.2015.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7655_CR66","doi-asserted-by":"publisher","unstructured":"Ellinsworth DC, Sandow SL, Shukla N, et al. Endothelium-derived hyperpolarization and coronary vasodilation: diverse and integrated roles of epoxyeicosatrienoic acids, hydrogen peroxide, and gap junctions. Microcirculation. 2016;23(1):15\u201332. https:\/\/doi.org\/10.1111\/micc.12255.","DOI":"10.1111\/micc.12255"},{"key":"7655_CR67","doi-asserted-by":"publisher","unstructured":"Malacarne PF, Bezzenberger J, Lopez M, et al. Epoxyeicosatrienoic acid and prostanoid crosstalk at the receptor and intracellular signaling levels to maintain vascular tone. Int J Mol Sci. 2022;23(11). https:\/\/doi.org\/10.3390\/ijms23115939.","DOI":"10.3390\/ijms23115939"},{"issue":"5 Pt 2","key":"7655_CR68","first-page":"F822","volume":"270","author":"AP Zou","year":"1996","unstructured":"Zou AP, Fleming JT, Falck JR, et al. Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. Am J Physiol. 1996;270(5 Pt 2):F822\u201332.","journal-title":"Am J Physiol"},{"issue":"1","key":"7655_CR69","doi-asserted-by":"publisher","first-page":"F155","DOI":"10.1152\/ajprenal.00231.2005","volume":"291","author":"MA Carroll","year":"2006","unstructured":"Carroll MA, Doumad AB, Li J, et al. Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP\/PKA pathway. Am J Physiol Renal Physiol. 2006;291(1):F155\u201361. https:\/\/doi.org\/10.1152\/ajprenal.00231.2005.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"7655_CR70","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/cvr\/cvu190","volume":"104","author":"P Zhang","year":"2014","unstructured":"Zhang P, Ma Y, Wang Y, et al. Nitric oxide and protein kinase G act on TRPC1 to inhibit 11,12-EET-induced vascular relaxation. Cardiovasc Res. 2014;104(1):138\u201346. https:\/\/doi.org\/10.1093\/cvr\/cvu190.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"7655_CR71","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.bbalip.2015.04.008","volume":"1851","author":"S Eryanni-Levin","year":"2015","unstructured":"Eryanni-Levin S, Khatib S, Levy-Rosenzvig R, Tamir S, Szuchman-Sapir A. 5,6-delta-DHTL, a stable metabolite of arachidonic acid, is a potential substrate for paraoxonase 1. Biochem Biophys Acta. 2015;1851(9):1118\u201322. https:\/\/doi.org\/10.1016\/j.bbalip.2015.04.008.","journal-title":"Biochem Biophys Acta"},{"issue":"9","key":"7655_CR72","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00424-013-1411-0","volume":"466","author":"M Cazade","year":"2014","unstructured":"Cazade M, Bidaud I, Hansen PB, Lory P, Chemin J. 5,6-EET potently inhibits T-type calcium channels: implication in the regulation of the vascular tone. Pflugers Arch. 2014;466(9):1759\u201368. https:\/\/doi.org\/10.1007\/s00424-013-1411-0.","journal-title":"Pflugers Arch"},{"issue":"12","key":"7655_CR73","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1172\/jci60658","volume":"122","author":"M Rabinovitch","year":"2012","unstructured":"Rabinovitch M. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Investig. 2012;122(12):4306\u201313. https:\/\/doi.org\/10.1172\/jci60658.","journal-title":"J Clin Investig"},{"issue":"4","key":"7655_CR74","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s004240100565","volume":"442","author":"I Fleming","year":"2001","unstructured":"Fleming I, Fisslthaler B, Michaelis UR, et al. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflugers Arch. 2001;442(4):511\u20138.","journal-title":"Pflugers Arch"},{"issue":"18","key":"7655_CR75","doi-asserted-by":"publisher","first-page":"15671","DOI":"10.1074\/jbc.M110806200","volume":"277","author":"M Potente","year":"2002","unstructured":"Potente M, Michaelis UR, Fisslthaler B, Busse R, Fleming I. Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1. J Biol Chem. 2002;277(18):15671\u20136. https:\/\/doi.org\/10.1074\/jbc.M110806200.","journal-title":"J Biol Chem"},{"issue":"6","key":"7655_CR76","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1096\/fj.02-0640fje","volume":"17","author":"UR Michaelis","year":"2003","unstructured":"Michaelis UR, Fisslthaler B, Medhora M, et al. Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with the epidermal growth factor receptor (EGFR). FASEB J. 2003;17(6):770\u20132. https:\/\/doi.org\/10.1096\/fj.02-0640fje.","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"issue":"2","key":"7655_CR77","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1124\/jpet.105.083477","volume":"314","author":"Y Wang","year":"2005","unstructured":"Wang Y, Wei X, Xiao X, et al. Arachidonic acid epoxygenase metabolites stimulate endothelial cell growth and angiogenesis via mitogen-activated protein kinase and phosphatidylinositol 3-kinase\/Akt signaling pathways. J Pharmacol Exp Ther. 2005;314(2):522\u201332. https:\/\/doi.org\/10.1124\/jpet.105.083477.","journal-title":"J Pharmacol Exp Ther"},{"issue":"29","key":"7655_CR78","doi-asserted-by":"publisher","first-page":"27138","DOI":"10.1074\/jbc.M501730200","volume":"280","author":"A Pozzi","year":"2005","unstructured":"Pozzi A, Macias-Perez I, Abair T, et al. Characterization of 5,6- and 8,9-epoxyeicosatrienoic acids (5,6- and 8,9-EET) as potent in vivo angiogenic lipids. J Biol Chem. 2005;280(29):27138\u201346. https:\/\/doi.org\/10.1074\/jbc.M501730200.","journal-title":"J Biol Chem"},{"issue":"1","key":"7655_CR79","doi-asserted-by":"publisher","first-page":"H142","DOI":"10.1152\/ajpheart.00783.2006","volume":"293","author":"S Yang","year":"2007","unstructured":"Yang S, Lin L, Chen JX, et al. Cytochrome P-450 epoxygenases protect endothelial cells from apoptosis induced by tumor necrosis factor-alpha via MAPK and PI3K\/Akt signaling pathways. Am J Physiol Heart Circ Physiol. 2007;293(1):H142\u201351. https:\/\/doi.org\/10.1152\/ajpheart.00783.2006.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1\u20132","key":"7655_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.abb.2009.05.006","volume":"489","author":"S Yang","year":"2009","unstructured":"Yang S, Wei S, Pozzi A, Capdevila JH. The arachidonic acid epoxygenase is a component of the signaling mechanisms responsible for VEGF-stimulated angiogenesis. Arch Biochem Biophys. 2009;489(1\u20132):82\u201391. https:\/\/doi.org\/10.1016\/j.abb.2009.05.006.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"7655_CR81","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1194\/jlr.M024398","volume":"53","author":"J Ma","year":"2012","unstructured":"Ma J, Zhang L, Han W, et al. Activation of JNK\/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells. J Lipid Res. 2012;53(6):1093\u2013105. https:\/\/doi.org\/10.1194\/jlr.M024398.","journal-title":"J Lipid Res"},{"issue":"7","key":"7655_CR82","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1167\/iovs.14-14216","volume":"55","author":"ME Capozzi","year":"2014","unstructured":"Capozzi ME, McCollum GW, Penn JS. The role of cytochrome P450 epoxygenases in retinal angiogenesis. Invest Ophthalmol Vis Sci. 2014;55(7):4253\u201360. https:\/\/doi.org\/10.1167\/iovs.14-14216.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7655_CR83","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1074\/jbc.M503945200","volume":"281","author":"B Zhang","year":"2006","unstructured":"Zhang B, Cao H, Rao GN. Fibroblast growth factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14,15-epoxyeicosatrienoic acid-induced angiogenesis. J Biol Chem. 2006;281(2):905\u201314. https:\/\/doi.org\/10.1074\/jbc.M503945200.","journal-title":"J Biol Chem"},{"issue":"6","key":"7655_CR84","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1159\/000362950","volume":"33","author":"W Chen","year":"2014","unstructured":"Chen W, Zheng G, Yang S, et al. CYP2J2 and EETs protect against oxidative stress and apoptosis in vivo and in vitro following lung ischemia\/reperfusion. Cell Phys Biochem. 2014;33(6):1663\u201380. https:\/\/doi.org\/10.1159\/000362950.","journal-title":"Cell Phys Biochem: Int J Exp Cell Phys, Biochem Pharmacol"},{"key":"7655_CR85","doi-asserted-by":"publisher","unstructured":"Huang X-Y, Wang Y-G, Wang Y, Gao Y. Effect of ophiopogonin D in resisting vascular endothelial cell apoptosis induced by AngII through up-regulating CYP2J2\/EETs. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin Materia Medica. 2018;43(2):377\u201384. https:\/\/doi.org\/10.19540\/j.cnki.cjcmm.20171027.019.","DOI":"10.19540\/j.cnki.cjcmm.20171027.019"},{"key":"7655_CR86","doi-asserted-by":"publisher","unstructured":"Kr\u00fcger-Genge A, Blocki A, Franke R-P, Jung F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20(18). https:\/\/doi.org\/10.3390\/ijms20184411.","DOI":"10.3390\/ijms20184411"},{"issue":"6 Pt 2","key":"7655_CR87","first-page":"H2113","volume":"275","author":"X Fang","year":"1998","unstructured":"Fang X, Moore SA, Stoll LL, et al. 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. Am J Physiol. 1998;275(6 Pt 2):H2113\u201321.","journal-title":"Am J Physiol"},{"issue":"9","key":"7655_CR88","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1161\/01.RES.0000017727.35930.33","volume":"90","author":"J Sun","year":"2002","unstructured":"Sun J, Sui X, Bradbury JA, et al. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids. Circ Res. 2002;90(9):1020\u20137.","journal-title":"Circ Res"},{"issue":"3","key":"7655_CR89","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3892\/ijmm.2013.1435","volume":"32","author":"W Feng","year":"2013","unstructured":"Feng W, Xu X, Zhao G, et al. EETs and CYP2J2 inhibit TNF-alpha-induced apoptosis in pulmonary artery endothelial cells and TGF-beta1-induced migration in pulmonary artery smooth muscle cells. Int J Mol Med. 2013;32(3):685\u201393. https:\/\/doi.org\/10.3892\/ijmm.2013.1435.","journal-title":"Int J Mol Med"},{"issue":"11","key":"7655_CR90","doi-asserted-by":"publisher","first-page":"H1894","DOI":"10.1152\/ajpheart.00289.2015","volume":"309","author":"Q Wang","year":"2015","unstructured":"Wang Q, Huo L, He J, et al. Soluble epoxide hydrolase is involved in the development of atherosclerosis and arterial neointima formation by regulating smooth muscle cell migration. Am J Physiol Heart Circ Physiol. 2015;309(11):H1894\u2013903. https:\/\/doi.org\/10.1152\/ajpheart.00289.2015.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"7655_CR91","doi-asserted-by":"publisher","unstructured":"Kim HS, Kim SK, Kang KW. Differential effects of sEH inhibitors on the proliferation and migration of vascular smooth muscle cells. Int J Mol Sci. 2017;18(12). https:\/\/doi.org\/10.3390\/ijms18122683","DOI":"10.3390\/ijms18122683"},{"issue":"1","key":"7655_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11064-014-1456-2","volume":"40","author":"YY Qu","year":"2015","unstructured":"Qu YY, Yuan MY, Liu Y, Xiao XJ, Zhu YL. The protective effect of epoxyeicosatrienoic acids on cerebral ischemia\/reperfusion injury is associated with PI3K\/Akt pathway and ATP-sensitive potassium channels. Neurochem Res. 2015;40(1):1\u201314. https:\/\/doi.org\/10.1007\/s11064-014-1456-2","journal-title":"Neurochem Res"},{"key":"7655_CR93","doi-asserted-by":"publisher","unstructured":"Qu Y, Liu Y, Zhu Y, et al. Epoxyeicosatrienoic acid inhibits the apoptosis of cerebral microvascular smooth muscle cells by oxygen glucose deprivation via targeting the JNK\/c-Jun and mTOR signaling pathways. Mol Cells. 2017;40(11):837\u201346. https:\/\/doi.org\/10.14348\/molcells.2017.0084.","DOI":"10.14348\/molcells.2017.0084"},{"key":"7655_CR94","doi-asserted-by":"publisher","unstructured":"Liu R, Zhong L, Wang C, et al. MiR-3646 accelerates inflammatory response of Ang II-induced hVSMCs via CYP2J2\/EETs axis in hypertension model. Clin Exp Hypertension. 2023;45(1):2166948. https:\/\/doi.org\/10.1080\/10641963.2023.2166948","DOI":"10.1080\/10641963.2023.2166948"},{"key":"7655_CR95","doi-asserted-by":"publisher","first-page":"7265486","DOI":"10.1155\/2022\/7265486","volume":"2022","author":"J-H Tao","year":"2022","unstructured":"Tao J-H, Liu T, Zhang C-Y, et al. Epoxyeicosatrienoic acids inhibit the activation of murine fibroblasts by blocking the TGF-\u03b21-Smad2\/3 signaling in a PPAR\u03b3-dependent manner. Oxid Med Cell Longev. 2022;2022:7265486. https:\/\/doi.org\/10.1155\/2022\/7265486","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"7655_CR96","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s12276-021-00618-7","volume":"53","author":"HS Kim","year":"2021","unstructured":"Kim HS, Moon S-J, Lee SE, et al. The arachidonic acid metabolite 11,12-epoxyeicosatrienoic acid alleviates pulmonary fibrosis. Exp Mol Med. 2021;53(5):864\u201374. https:\/\/doi.org\/10.1038\/s12276-021-00618-7","journal-title":"Exp Mol Med"},{"issue":"7561","key":"7655_CR97","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nature14569","volume":"523","author":"P Li","year":"2015","unstructured":"Li P, Lahvic JL, Binder V, et al. Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment. Nature. 2015;523(7561):468\u201371. https:\/\/doi.org\/10.1038\/nature14569","journal-title":"Nature"},{"issue":"2","key":"7655_CR98","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000430113","volume":"36","author":"G Yu","year":"2015","unstructured":"Yu G, Zeng X, Wang H, et al. 14,15-epoxyeicosatrienoic acid suppresses cigarette smoke extract-induced apoptosis in lung epithelial cells by inhibiting endoplasmic reticulum stress. Cell Phys Biochem. 2015;36(2):474\u201386. https:\/\/doi.org\/10.1159\/000430113","journal-title":"Cell Phys Biochem: Int J Exp Cell Phys, Biochem, Pharm"},{"issue":"1","key":"7655_CR99","doi-asserted-by":"publisher","first-page":"H215","DOI":"10.1152\/ajpheart.01118.2001","volume":"284","author":"M Medhora","year":"2003","unstructured":"Medhora M, Daniels J, Mundey K, et al. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol. 2003;284(1):H215\u201324. https:\/\/doi.org\/10.1152\/ajpheart.01118.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"7655_CR100","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1165\/rcmb.2016-0418OC","volume":"57","author":"RA Alvarez","year":"2017","unstructured":"Alvarez RA, Miller MP, Hahn SA, et al. Targeting pulmonary endothelial hemoglobin \u03b1 improves nitric oxide signaling and reverses pulmonary artery endothelial dysfunction. Am J Respir Cell Mol Biol. 2017;57(6):733\u201344. https:\/\/doi.org\/10.1165\/rcmb.2016-0418OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"7655_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.yjmcc.2018.08.027","volume":"123","author":"Q Zhao","year":"2018","unstructured":"Zhao Q, Huang J, Wang D, et al. Endothelium-specific CYP2J2 overexpression improves cardiac dysfunction by promoting angiogenesis via Jagged1\/Notch1 signaling. J Mol Cell Cardiol. 2018;123:118\u201327. https:\/\/doi.org\/10.1016\/j.yjmcc.2018.08.027","journal-title":"J Mol Cell Cardiol"},{"key":"7655_CR102","doi-asserted-by":"publisher","unstructured":"Hung H-C, Syu J-N, Chao C-Y, et al. Neovasculogenic effect of 11,12-epoxyeicosatrienoic acid involves the Akt\/eNOS signaling pathways in human endothelial progenitor cells. BioMedicine. 2022;12(3):20\u201330. https:\/\/doi.org\/10.37796\/2211-8039.1343","DOI":"10.37796\/2211-8039.1343"},{"issue":"12","key":"7655_CR103","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1182\/blood-2007-11-126680","volume":"111","author":"SY Cheranov","year":"2008","unstructured":"Cheranov SY, Karpurapu M, Wang D, et al. An essential role for SRC-activated STAT-3 in 14,15-EET-induced VEGF expression and angiogenesis. Blood. 2008;111(12):5581\u201391. https:\/\/doi.org\/10.1182\/blood-2007-11-126680","journal-title":"Blood"},{"issue":"1","key":"7655_CR104","doi-asserted-by":"publisher","first-page":"e0209158","DOI":"10.1371\/journal.pone.0209158","volume":"14","author":"K Sommer","year":"2019","unstructured":"Sommer K, Jakob H, Badjlan F, et al. 11,12 and 14,15 epoxyeicosatrienoic acid rescue deteriorated wound healing in ischemia. PLoS ONE. 2019;14(1):e0209158. https:\/\/doi.org\/10.1371\/journal.pone.0209158.","journal-title":"PLoS ONE"},{"issue":"Pt 23","key":"7655_CR105","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.1242\/jcs.02674","volume":"118","author":"UR Michaelis","year":"2005","unstructured":"Michaelis UR, Fisslthaler B, Barbosa-Sicard E, et al. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci. 2005;118(Pt 23):5489\u201398. https:\/\/doi.org\/10.1242\/jcs.02674.","journal-title":"J Cell Sci"},{"issue":"5","key":"7655_CR106","doi-asserted-by":"publisher","first-page":"C1292","DOI":"10.1152\/ajpcell.00230.2008","volume":"295","author":"AC Webler","year":"2008","unstructured":"Webler AC, Michaelis UR, Popp R, et al. Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol. 2008;295(5):C1292\u2013301. https:\/\/doi.org\/10.1152\/ajpcell.00230.2008.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"7655_CR107","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1194\/jlr.M094219","volume":"60","author":"AA Rand","year":"2019","unstructured":"Rand AA, Rajamani A, Kodani SD, et al. Epoxyeicosatrienoic acid (EET)-stimulated angiogenesis is mediated by epoxy hydroxyeicosatrienoic acids (EHETs) formed from COX-2. J Lipid Res. 2019;60(12):1996\u20132005. https:\/\/doi.org\/10.1194\/jlr.M094219.","journal-title":"J Lipid Res"},{"issue":"1","key":"7655_CR108","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/circresaha.113.301141","volume":"115","author":"M Rabinovitch","year":"2014","unstructured":"Rabinovitch M, Guignabert C, Humbert M, Nicolls MR. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. Circ Res. 2014;115(1):165\u201375. https:\/\/doi.org\/10.1161\/circresaha.113.301141.","journal-title":"Circ Res"},{"issue":"1","key":"7655_CR109","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.yjmcc.2012.04.008","volume":"53","author":"SN Batchu","year":"2012","unstructured":"Batchu SN, Chaudhary KR, El-Sikhry H, et al. Role of PI3Kalpha and sarcolemmal ATP-sensitive potassium channels in epoxyeicosatrienoic acid mediated cardioprotection. J Mol Cell Cardiol. 2012;53(1):43\u201352. https:\/\/doi.org\/10.1016\/j.yjmcc.2012.04.008.","journal-title":"J Mol Cell Cardiol"},{"key":"7655_CR110","doi-asserted-by":"publisher","first-page":"e885","DOI":"10.1038\/cddis.2013.418","volume":"4","author":"V Samokhvalov","year":"2013","unstructured":"Samokhvalov V, Alsaleh N, El-Sikhry HE, et al. Epoxyeicosatrienoic acids protect cardiac cells during starvation by modulating an autophagic response. Cell Death Dis. 2013;4:e885. https:\/\/doi.org\/10.1038\/cddis.2013.418.","journal-title":"Cell Death Dis"},{"key":"7655_CR111","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fphar.2016.00133","volume":"7","author":"MK Akhnokh","year":"2016","unstructured":"Akhnokh MK, Yang FH, Samokhvalov V, et al. Inhibition of soluble epoxide hydrolase limits mitochondrial damage and preserves function following ischemic injury. Front Pharmacol. 2016;7:133. https:\/\/doi.org\/10.3389\/fphar.2016.00133.","journal-title":"Front Pharmacol"},{"issue":"4","key":"7655_CR112","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00001.2013","volume":"306","author":"P Sarkar","year":"2014","unstructured":"Sarkar P, Zaja I, Bienengraeber M, et al. Epoxyeicosatrienoic acids pretreatment improves amyloid beta-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes. Am J Physiol Heart Circ Physiol. 2014;306(4):H475\u201384. https:\/\/doi.org\/10.1152\/ajpheart.00001.2013.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"7655_CR113","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.bbrc.2014.06.022","volume":"450","author":"L Wang","year":"2014","unstructured":"Wang L, Chen M, Yuan L, et al. 14,15-EET promotes mitochondrial biogenesis and protects cortical neurons against oxygen\/glucose deprivation-induced apoptosis. Biochem Biophys Res Commun. 2014;450(1):604\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2014.06.022.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"7655_CR114","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","volume":"87","author":"Z Yu","year":"2000","unstructured":"Yu Z, Xu F, Huse LM, et al. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids. Circ Res. 2000;87(11):992\u20138.","journal-title":"Circ Res"},{"key":"7655_CR115","doi-asserted-by":"publisher","unstructured":"Khan MAH, Pavlov TS, Christain SV, et al. Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition. Clin Sci (London, England: 1979). 2014;127(7):463\u201374. https:\/\/doi.org\/10.1042\/cs20130479.","DOI":"10.1042\/cs20130479"},{"issue":"10","key":"7655_CR116","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrd2875","volume":"8","author":"JD Imig","year":"2009","unstructured":"Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discovery. 2009;8(10):794\u2013805. https:\/\/doi.org\/10.1038\/nrd2875.","journal-title":"Nat Rev Drug Discovery"},{"key":"7655_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.06.015","volume":"192","author":"JD Imig","year":"2018","unstructured":"Imig JD. Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics. Pharmacol Ther. 2018;192:1\u201319. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.06.015.","journal-title":"Pharmacol Ther"},{"key":"7655_CR118","doi-asserted-by":"publisher","unstructured":"Imig JD. Epoxyeicosatrienoic acids, hypertension, and kidney injury. Hypertension. 2015;65(3):476\u201382. https:\/\/doi.org\/10.1161\/hypertensionaha.114.03585.","DOI":"10.1161\/hypertensionaha.114.03585"},{"issue":"3","key":"7655_CR119","doi-asserted-by":"publisher","first-page":"R321","DOI":"10.1152\/ajpregu.00606.2011","volume":"302","author":"AA Elmarakby","year":"2012","unstructured":"Elmarakby AA. Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease. Am J Physiol Regul Integr Comp Physiol. 2012;302(3):R321\u201330. https:\/\/doi.org\/10.1152\/ajpregu.00606.2011.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"7655_CR120","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1159\/000487902","volume":"43","author":"V\u010c Ch\u00e1bov\u00e1","year":"2018","unstructured":"Ch\u00e1bov\u00e1 V\u010c, Kujal P, \u0160karoupkov\u00e1 P, et al. Combined inhibition of soluble epoxide hydrolase and renin-angiotensin system exhibits superior renoprotection to renin-angiotensin system blockade in 5\/6 nephrectomized ren-2 transgenic hypertensive rats with established chronic kidney disease. Kidney Blood Press Res. 2018;43(2):329\u201349. https:\/\/doi.org\/10.1159\/000487902.","journal-title":"Kidney Blood Press Res"},{"issue":"10","key":"7655_CR121","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1681\/asn.2017030252","volume":"28","author":"F Fan","year":"2017","unstructured":"Fan F, Roman RJ. Effect of cytochrome P450 metabolites of arachidonic acid in nephrology. J Am Soc Nephrol. 2017;28(10):2845\u201355. https:\/\/doi.org\/10.1681\/asn.2017030252.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"7655_CR122","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/ki.2009.67","volume":"75","author":"X Liu","year":"2009","unstructured":"Liu X, Zhao Y, Wang L, et al. Overexpression of cytochrome P450 4F2 in mice increases 20-hydroxyeicosatetraenoic acid production and arterial blood pressure. Kidney Int. 2009;75(12):1288\u201396. https:\/\/doi.org\/10.1038\/ki.2009.67.","journal-title":"Kidney Int"},{"key":"7655_CR123","doi-asserted-by":"publisher","unstructured":"Lasker JM, Chen WB, Wolf I, et al. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J Biol Chem. 2000;275(6):4118\u201326. https:\/\/doi.org\/10.1074\/jbc.275.6.4118.","DOI":"10.1074\/jbc.275.6.4118"},{"issue":"3","key":"7655_CR124","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.nefroe.2024.01.020","volume":"44","author":"MA Su\u00e1rez-Santisteban","year":"2024","unstructured":"Su\u00e1rez-Santisteban MA, Santos-D\u00edaz G, Garc\u00eda-Bernalt V, et al. Association between CYP4A11 and EPHX2 genetic polymorphisms and chronic kidney disease progression in hypertensive patients. Nefrologia. 2024;44(3):382\u201395. https:\/\/doi.org\/10.1016\/j.nefroe.2024.01.020.","journal-title":"Nefrologia"},{"issue":"6","key":"7655_CR125","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/FJC.0000000000000371","volume":"67","author":"W Liu","year":"2016","unstructured":"Liu W, Wang T, He X, et al. CYP2J2 overexpression increases EETs and protects against HFD-induced atherosclerosis in ApoE-\/- Mice. J Cardiovasc Pharmacol. 2016;67(6):491\u2013502. https:\/\/doi.org\/10.1097\/FJC.0000000000000371.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"7655_CR126","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1161\/ATVBAHA.109.186064","volume":"29","author":"LN Zhang","year":"2009","unstructured":"Zhang LN, Vincelette J, Cheng Y, et al. Inhibition of soluble epoxide hydrolase attenuated atherosclerosis, abdominal aortic aneurysm formation, and dyslipidemia. Arterioscler Thromb Vasc Biol. 2009;29(9):1265\u201370. https:\/\/doi.org\/10.1161\/ATVBAHA.109.186064.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7655_CR127","doi-asserted-by":"publisher","unstructured":"Aliwarga T, Dinh JC, Heyward S, et al. Cardiac disease alters myocardial tissue levels of epoxyeicosatrienoic acids and key proteins involved in their biosynthesis and degradation. Int J Mol Sci. 2022;23(20). https:\/\/doi.org\/10.3390\/ijms232012433.","DOI":"10.3390\/ijms232012433"},{"issue":"1","key":"7655_CR128","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12033-007-0054-9","volume":"37","author":"C Ferreri","year":"2007","unstructured":"Ferreri C, Panagiotaki M, Chatgilialoglu C. Trans fatty acids in membranes: the free radical path. Mol Biotechnol. 2007;37(1):19\u201325. https:\/\/doi.org\/10.1007\/s12033-007-0054-9.","journal-title":"Mol Biotechnol"},{"issue":"3","key":"7655_CR129","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1093\/advances\/nmz125","volume":"11","author":"A-B Oteng","year":"2020","unstructured":"Oteng A-B, Kersten S. Mechanisms of action of trans fatty acids. Advances in nutrition (Bethesda, Md). 2020;11(3):697\u2013708. https:\/\/doi.org\/10.1093\/advances\/nmz125.","journal-title":"Advances in nutrition (Bethesda, Md)"},{"key":"7655_CR130","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.freeradbiomed.2017.07.015","volume":"112","author":"T Aliwarga","year":"2017","unstructured":"Aliwarga T, Raccor BS, Lemaitre RN, et al. Enzymatic and free radical formation of cis- and trans- epoxyeicosatrienoic acids in vitro and in vivo. Free Radical Biol Med. 2017;112:131\u201340. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.07.015.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"7655_CR131","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1194\/jlr.M061697","volume":"57","author":"A Oni-Orisan","year":"2016","unstructured":"Oni-Orisan A, Edin ML, Lee JA, et al. Cytochrome P450-derived epoxyeicosatrienoic acids and coronary artery disease in humans: a targeted metabolomics study. J Lipid Res. 2016;57(1):109\u201319. https:\/\/doi.org\/10.1194\/jlr.M061697.","journal-title":"J Lipid Res"},{"issue":"6","key":"7655_CR132","doi-asserted-by":"publisher","first-page":"H2838","DOI":"10.1152\/ajpheart.00186.2008","volume":"294","author":"GJ Gross","year":"2008","unstructured":"Gross GJ, Gauthier KM, Moore J, et al. Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart. Am J Physiol Heart Circ Physiol. 2008;294(6):H2838\u201344. https:\/\/doi.org\/10.1152\/ajpheart.00186.2008.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"7655_CR133","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.yjmcc.2006.11.020","volume":"42","author":"GJ Gross","year":"2007","unstructured":"Gross GJ, Hsu A, Falck JR, Nithipatikom K. Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. J Mol Cell Cardiol. 2007;42(3):687\u201391. https:\/\/doi.org\/10.1016\/j.yjmcc.2006.11.020.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"7655_CR134","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1152\/physrev.00021.2011","volume":"92","author":"JD Imig","year":"2012","unstructured":"Imig JD. Epoxides and soluble epoxide hydrolase in cardiovascular physiology. Physiol Rev. 2012;92(1):101\u201330. https:\/\/doi.org\/10.1152\/physrev.00021.2011.","journal-title":"Physiol Rev"},{"key":"7655_CR135","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.yjmcc.2014.05.016","volume":"74","author":"A Oni-Orisan","year":"2014","unstructured":"Oni-Orisan A, Alsaleh N, Lee CR, Seubert JM. Epoxyeicosatrienoic acids and cardioprotection: the road to translation. J Mol Cell Cardiol. 2014;74:199\u2013208. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.05.016.","journal-title":"J Mol Cell Cardiol"},{"key":"7655_CR136","doi-asserted-by":"publisher","first-page":"104189","DOI":"10.1016\/j.ebiom.2022.104189","volume":"83","author":"RN Lemaitre","year":"2022","unstructured":"Lemaitre RN, Jensen PN, Zeigler M, et al. Plasma epoxyeicosatrienoic acids and diabetes-related cardiovascular disease: the cardiovascular health study. EBioMedicine. 2022;83:104189. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104189.","journal-title":"EBioMedicine"},{"key":"7655_CR137","doi-asserted-by":"publisher","unstructured":"Zhang D, Xie X, Chen Y, et al. Homocysteine upregulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo. Circulation Res. 2012;110(6):808\u201317.https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.259325.","DOI":"10.1161\/CIRCRESAHA.111.259325"},{"issue":"4","key":"7655_CR138","doi-asserted-by":"publisher","first-page":"166643","DOI":"10.1016\/j.bbadis.2023.166643","volume":"1869","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Wang X-C, Wei J-H, et al. Soluble epoxide hydrolase and TRPC3 channels jointly contribute to homocysteine-induced cardiac hypertrophy: interrelation and regulation by C\/EBP\u03b2. Biochim Biophys Acta. 2023;1869(4):166643. https:\/\/doi.org\/10.1016\/j.bbadis.2023.166643.","journal-title":"Biochim Biophys Acta"},{"key":"7655_CR139","doi-asserted-by":"publisher","first-page":"106620","DOI":"10.1016\/j.prostaglandins.2022.106620","volume":"159","author":"J Zhang","year":"2022","unstructured":"Zhang J, Yang C, Qiu H, et al. 14,15-EET involved in the development of diabetic cardiac hypertrophy mediated by PPARs. Prostaglandins Other Lipid Mediat. 2022;159:106620. https:\/\/doi.org\/10.1016\/j.prostaglandins.2022.106620.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"49","key":"7655_CR140","doi-asserted-by":"publisher","first-page":"18733","DOI":"10.1073\/pnas.0609158103","volume":"103","author":"D Xu","year":"2006","unstructured":"Xu D, Li N, He Y, et al. Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors. Proc Natl Acad Sci USA. 2006;103(49):18733\u20138. https:\/\/doi.org\/10.1073\/pnas.0609158103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7655_CR141","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12507","author":"B Wang","year":"2016","unstructured":"Wang B, Zeng H, Wen Z, Chen C, Wang DW. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKalpha2 and enhancing nuclear translocation of Akt1. Aging Cell. 2016. https:\/\/doi.org\/10.1111\/acel.12507.","journal-title":"Aging Cell"},{"issue":"8","key":"7655_CR142","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1124\/dmd.115.063776","volume":"43","author":"HN Althurwi","year":"2015","unstructured":"Althurwi HN, Maayah ZH, Elshenawy OH, El-Kadi AO. Early changes in cytochrome P450s and their associated arachidonic acid metabolites play a crucial role in the initiation of cardiac hypertrophy induced by isoproterenol. Drug Metab Disposition: Biol Fate Chem. 2015;43(8):1254\u201366. https:\/\/doi.org\/10.1124\/dmd.115.063776.","journal-title":"Drug Metab Disposition: Biol Fate Chem"},{"issue":"3","key":"7655_CR143","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","volume":"87","author":"AA El-Sherbeni","year":"2014","unstructured":"El-Sherbeni AA, El-Kadi AO. Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy. Biochem Pharmacol. 2014;87(3):456\u201366. https:\/\/doi.org\/10.1016\/j.bcp.2013.11.015.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"7655_CR144","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1254\/jphs.08122FP","volume":"108","author":"S Suzuki","year":"2008","unstructured":"Suzuki S, Oguro A, Osada-Oka M, Funae Y, Imaoka S. Epoxyeicosatrienoic acids and\/or their metabolites promote hypoxic response of cells. J Pharmacol Sci. 2008;108(1):79\u201388.","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"7655_CR145","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1096\/fj.08-112821","volume":"22","author":"B Keseru","year":"2008","unstructured":"Keseru B, Barbosa-Sicard E, Popp R, et al. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. FASEB J: Off Publ Fed Am Soc Exp Biol. 2008;22(12):4306\u201315. https:\/\/doi.org\/10.1096\/fj.08-112821.","journal-title":"FASEB J: Off Publ Fed Am Soc Exp Biol"},{"key":"7655_CR146","doi-asserted-by":"publisher","unstructured":"Keseru B, Barbosa-Sicard E, Schermuly RT, et al. Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc Res. 2010;85(1):232\u201340. https:\/\/doi.org\/10.1093\/cvr\/cvp281.","DOI":"10.1093\/cvr\/cvp281"},{"issue":"4","key":"7655_CR147","doi-asserted-by":"publisher","first-page":"204589401989594","DOI":"10.1177\/2045894019895947","volume":"9","author":"S Kandhi","year":"2019","unstructured":"Kandhi S, Alruwaili N, Wolin MS, Sun D, Huang A. Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs. Pulmon Circulation. 2019;9(4):2045894019895947. https:\/\/doi.org\/10.1177\/2045894019895947.","journal-title":"Pulmon Circulation"},{"issue":"2","key":"7655_CR148","doi-asserted-by":"publisher","first-page":"L350","DOI":"10.1152\/ajplung.00038.2017","volume":"313","author":"S Kandhi","year":"2017","unstructured":"Kandhi S, Zhang B, Froogh G, et al. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids. Am J Physiol Lung Cell Mol Physiol. 2017;313(2):L350\u20139. https:\/\/doi.org\/10.1152\/ajplung.00038.2017.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"7655_CR149","doi-asserted-by":"publisher","first-page":"e1003950","DOI":"10.1371\/journal.pgen.1003950","volume":"9","author":"GL Zhou","year":"2013","unstructured":"Zhou GL, Beloiartsev A, Yu B, et al. Deletion of the murine cytochrome P450 Cyp2j locus by fused BAC-mediated recombination identifies a role for Cyp2j in the pulmonary vascular response to hypoxia. PLoS Genet. 2013;9(11):e1003950. https:\/\/doi.org\/10.1371\/journal.pgen.1003950.","journal-title":"PLoS Genet"},{"issue":"5","key":"7655_CR150","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1165\/rcmb.2013-0482OC","volume":"52","author":"A Beloiartsev","year":"2015","unstructured":"Beloiartsev A, da Gloria R-M, Zhou GL, et al. Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j. Am J Respir Cell Mol Biol. 2015;52(5):563\u201370. https:\/\/doi.org\/10.1165\/rcmb.2013-0482OC.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"7655_CR151","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00408-018-0145-3","volume":"196","author":"Y Xia","year":"2018","unstructured":"Xia Y, Xia L, Lou L, et al. Transient receptor potential channels and chronic airway inflammatory diseases: a comprehensive review. Lung. 2018;196(5):505\u201316. https:\/\/doi.org\/10.1007\/s00408-018-0145-3.","journal-title":"Lung"},{"key":"7655_CR152","doi-asserted-by":"publisher","first-page":"8927381","DOI":"10.1155\/2020\/8927381","volume":"2020","author":"Y Xia","year":"2020","unstructured":"Xia Y, Xia L, Jin Z, et al. Cytochrome P450 Epoxygenase-dependent activation of TRPV4 channel participates in enhanced serotonin-induced pulmonary vasoconstriction in chronic hypoxic pulmonary hypertension. Anal Cell Pathol (Amst). 2020;2020:8927381. https:\/\/doi.org\/10.1155\/2020\/8927381.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"130","key":"7655_CR153","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1183\/09059180.00007513","volume":"22","author":"C Guignabert","year":"2013","unstructured":"Guignabert C, Tu L, Hiress ML, et al. Pathogenesis of pulmonary arterial hypertension: lessons from cancer. Eur Respiratory Review: Off J Eur Respir Soc. 2013;22(130):543\u201351. https:\/\/doi.org\/10.1183\/09059180.00007513.","journal-title":"Eur Respiratory Review: Off J Eur Respir Soc"},{"issue":"6","key":"7655_CR154","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1164\/rccm.200709-1369PP","volume":"178","author":"PR Rai","year":"2008","unstructured":"Rai PR, Cool CD, King JAC, et al. The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;178(6):558\u201364. https:\/\/doi.org\/10.1164\/rccm.200709-1369PP.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"7655_CR155","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1158\/0008-5472.CAN-04-4173","volume":"65","author":"JG Jiang","year":"2005","unstructured":"Jiang JG, Chen CL, Card JW, et al. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Can Res. 2005;65(11):4707\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-4173.","journal-title":"Can Res"},{"issue":"14","key":"7655_CR156","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1158\/0008-5472.CAN-06-3643","volume":"67","author":"JG Jiang","year":"2007","unstructured":"Jiang JG, Ning YG, Chen C, et al. Cytochrome p450 epoxygenase promotes human cancer metastasis. Can Res. 2007;67(14):6665\u201374. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-3643.","journal-title":"Can Res"},{"issue":"3","key":"7655_CR157","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1089\/omi.2022.0185","volume":"27","author":"EK Oktem","year":"2023","unstructured":"Oktem EK, Aydin B, Gulfidan G, Arga KY. A transcriptomic and reverse-engineering strategy reveals molecular signatures of arachidonic acid metabolism in 12 cancers. OMICS. 2023;27(3):127\u201338. https:\/\/doi.org\/10.1089\/omi.2022.0185.","journal-title":"OMICS"},{"issue":"1","key":"7655_CR158","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, et al. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94. https:\/\/doi.org\/10.1038\/s41392-020-00443-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"7655_CR159","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1172\/JCI58128","volume":"122","author":"D Panigrahy","year":"2012","unstructured":"Panigrahy D, Edin ML, Lee CR, et al. Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Investig. 2012;122(1):178\u201391. https:\/\/doi.org\/10.1172\/JCI58128.","journal-title":"J Clin Investig"},{"key":"7655_CR160","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.biochi.2020.02.014","volume":"171\u2013172","author":"C Colombero","year":"2020","unstructured":"Colombero C, C\u00e1rdenas S, Venara M, et al. Cytochrome 450 metabolites of arachidonic acid (20-HETE, 11,12-EET and 14,15-EET) promote pheochromocytoma cell growth and tumor associated angiogenesis. Biochimie. 2020;171\u2013172:147\u201357. https:\/\/doi.org\/10.1016\/j.biochi.2020.02.014.","journal-title":"Biochimie"},{"issue":"20","key":"7655_CR161","doi-asserted-by":"publisher","first-page":"17543","DOI":"10.1074\/jbc.M110.198515","volume":"286","author":"R Mitra","year":"2011","unstructured":"Mitra R, Guo Z, Milani M, et al. CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (+\/-)-14,15-epoxyeicosatrienoic acid (EET). J Biol Chem. 2011;286(20):17543\u201359. https:\/\/doi.org\/10.1074\/jbc.M110.198515.","journal-title":"J Biol Chem"},{"key":"7655_CR162","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/1471-2407-14-841","volume":"14","author":"X Wei","year":"2014","unstructured":"Wei X, Zhang D, Dou X, et al. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer. BMC Cancer. 2014;14:841. https:\/\/doi.org\/10.1186\/1471-2407-14-841.","journal-title":"BMC Cancer"},{"issue":"1","key":"7655_CR163","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","volume":"37","author":"J Luo","year":"2018","unstructured":"Luo J, Yao J-F, Deng X-F, et al. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin \u03b1v\u03b23 and activating FAK\/PI3K\/AKT signaling. J Exp Clin Cancer Res: CR. 2018;37(1):23. https:\/\/doi.org\/10.1186\/s13046-018-0694-6.","journal-title":"J Exp Clin Cancer Res: CR"},{"issue":"2","key":"7655_CR164","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1158\/0008-5472.CAN-13-1928","volume":"74","author":"N Skrypnyk","year":"2014","unstructured":"Skrypnyk N, Chen X, Hu W, et al. PPARalpha activation can help prevent and treat non-small cell lung cancer. Can Res. 2014;74(2):621\u201331. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-1928.","journal-title":"Can Res"},{"key":"7655_CR165","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9709","author":"J Luo","year":"2016","unstructured":"Luo J, Feng XX, Luo C, et al. 14,15-EET induces the infiltration and tumor-promoting function of neutrophils to trigger the growth of minimal dormant metastases. Oncotarget. 2016. https:\/\/doi.org\/10.18632\/oncotarget.9709.","journal-title":"Oncotarget"},{"issue":"17","key":"7655_CR166","doi-asserted-by":"publisher","first-page":"12840","DOI":"10.1074\/jbc.M109.081554","volume":"285","author":"A Pozzi","year":"2010","unstructured":"Pozzi A, Popescu V, Yang S, et al. The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated. J Biol Chem. 2010;285(17):12840\u201350. https:\/\/doi.org\/10.1074\/jbc.M109.081554.","journal-title":"J Biol Chem"},{"issue":"17","key":"7655_CR167","doi-asserted-by":"publisher","first-page":"4865","DOI":"10.1158\/0008-5472.Can-17-3977","volume":"78","author":"LN Sausville","year":"2018","unstructured":"Sausville LN, Gangadhariah MH, Chiusa M, et al. The cytochrome P450 slow metabolizers CYP2C9*2 and CYP2C9*3 directly regulate tumorigenesis via reduced epoxyeicosatrienoic acid production. Can Res. 2018;78(17):4865\u201377. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-3977.","journal-title":"Can Res"},{"issue":"30","key":"7655_CR168","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1073\/pnas.1410432111","volume":"111","author":"G Zhang","year":"2014","unstructured":"Zhang G, Panigrahy D, Hwang SH, et al. Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci USA. 2014;111(30):11127\u201332. https:\/\/doi.org\/10.1073\/pnas.1410432111.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07655-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07655-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T07:01:17Z","timestamp":1766127677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07655-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":168,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7655"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07655-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"20 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}